KEIWA INCORPORATED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,676 JPY | +0.36% |
|
+6.01% | +30.94% |
| 2023 | KEIWA Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2021 | KEIWA Incorporated(TSE:4251) added to S&P Global BMI Index | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The company returns high margins, thereby supporting business profitability.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 10.38 for the current year.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart - Surperformance
Sector: Commodity Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +30.94% | 207M | - | ||
| +4.47% | 106B | A- | ||
| -11.62% | 59.18B | A- | ||
| +67.14% | 46.59B | B | ||
| +12.80% | 37.58B | B | ||
| +0.87% | 31.23B | A- | ||
| +10.29% | 16.46B | C+ | ||
| +7.82% | 13.81B | B- | ||
| -5.51% | 12.93B | B | ||
| -24.66% | 12.32B | B+ |
Investor Rating
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 4251 Stock
- Ratings KEIWA Incorporated
